Loading...
Long-term safety of aromatase inhibitors in the treatment of breast cancer
Following promising data for metastatic breast cancer in terms of efficacy and safety profile, third-generation aromatase inhibitors (AI), anastrozole, letrozole, and exemestane, underwent a full development in early setting. If recent results consistently show the superiority of these agents over t...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503653/ https://ncbi.nlm.nih.gov/pubmed/18728707 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|